Boston Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Boston Therapeutics generated cash of -$784,299, which is more than the previous year. Cash used in financing activities reached the amount of $785,000 last year. Net change in cash is therefore $701.
Cash Flow
| 2012 | -852.92K | -7.75K | 1.18M |
|---|---|---|---|
| 2013 | -2.33M | -10.91K | 5.18M |
| 2014 | -3.47M | -6.51K | 250.5K |
| 2015 | -1.29M | 0 | 1.17M |
| 2016 | -1.24M | 0 | 1.89M |
| 2017 | -1.27M | -4.70K | 730K |
| 2018 | -883.84K | 3.59K | 755.43K |
| 2019 | -1.19M | 0 | 1.19M |
| 2020 | -784.29K | 0 | 785K |
BTHE Cash Flow Statement (2012 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 6.70K | 12.46K | 137.27K | 687.18K | 40.99K | 157.27K | 3.38M | 552.31K | 225.99K |
Operating activities | |||||||||
Net income | -907.88K | -3.69M | -3.60M | -1.58M | -3.73M | -2.48M | -4.69M | -4.60M | -1.48M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 509 | 149.65K | 159.90K | 67.00K | 70.37K | 71.03K | 70.94K | 67.10K | 64.96K |
Stock-based compensation expense | 0 | 144.82K | 175.07K | 49.75K | 238.31K | 279.78K | 762.00K | 1.55M | 480.10K |
| Deferred income tax benefit | 0 | 144.82K | 175.07K | 49.75K | 238.31K | 279.78K | 762.00K | 1.55M | 480.10K |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 7.46M | 384 | 204 | 4.42K | -5.01K | 145.02K | 99.78K | -82.43K | -17.35K |
Inventories | 1.68K | -2.89K | 5.77K | 3.57K | 54.63K | -24.18K | -87.34K | -93.81K | 6.78K |
Accounts payable | 202.73K | 100.65K | 46.35K | -20.21K | 213.29K | 225.14K | 239.81K | -123.21K | -47.68K |
Cash generated by operating activities | -784.29K | -1.19M | -883.84K | -1.27M | -1.24M | -1.29M | -3.47M | -2.33M | -852.92K |
Investing activities | |||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | -4.70K | 0 | 0 | -6.51K | -10.91K | -7.75K |
Acquisitions Net | 0 | 0 | 3.59K | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 3.59K | -4.70K | 0 | 0 | -6.51K | -10.91K | -7.75K |
Financing activities | |||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 200K | 250K | 5.18M | 1.14M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -50K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 785K | 1.19M | 755.43K | 730K | 1.89M | 1.17M | 250.5K | 5.18M | 1.18M |
Net Change In Cash | 701 | -5.76K | -124.81K | -549.90K | 646.19K | -116.28K | -3.23M | 2.83M | 326.32K |
Cash at end of period | 7.40K | 6.70K | 12.46K | 137.27K | 687.18K | 40.99K | 157.27K | 3.38M | 552.31K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |